New Breast Cancer Treatment Extends Survival Significantly

A groundbreaking combination therapy is giving women with HER2-positive metastatic breast cancer significantly more time, setting a new standard for first-line treatment.

The DESTINY-Breast09 trial shows the treatment works across different patient groups, offering hope to thousands.